Jump to main content
博士論文

Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease

Persistent ID (NDL)
info:ndljp/pid/12317095
Material type
博士論文
Author
上原, 拓也
Publisher
上原, 拓也
Publication date
2020
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
大阪大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
上原, 拓也
Publication, Distribution, etc.
Publication Date
2020
Publication Date (W3CDTF)
2020
Alternative Title
α-シヌクレインを標的としたAmNA搭載アンチセンス核酸によるパーキンソン病の新規治療
Degree grantor/type
大阪大学
Date Granted
2020-01-31
Date Granted (W3CDTF)
2020-01-31